AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9288517
Drug: Hamburg cardioplegic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hamburg cardioplegic solution
Trial: 8385552
Drug: Oral tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tramadol HCL 100 mg (Group A)
Trial: 3943275
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of alanine
Trial: 26049730
Drug: Transvenous vagus
RxNorm normalized name: Sus scrofa vagus nerve preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transvenous vagus nerve stimulation (tVNS) for 30 minutes (0-10 V, 1 ms, 20 Hz) starting 10 minutes before LPS administration (2 ng kg(-1) Escherichia coli lipopolysaccharide)
Trial: 19455196
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment in dialysis unit
Trial: 16980747
Drug: Epoetin alpha
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alpha (40,000 IU weekly)
Trial: 16980747
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (RBV dose reduction from 1000/1200 to 800/600 mg)
Trial: 2888421
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg morphine
Trial: 3553135
Drug: ceftizoxime (2-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ceftizoxime (2-4 g every 8 h)
Trial: 24868083
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose combination treatment (aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg with either atenolol 50 mg or hydrochlorothiazide 12.5 mg)
Trial: 20199139
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg once daily for 16 days, then tapered to 5 mg for 14 days
Trial: 20199139
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once daily for 16 days, then tapered to 30 mg for 14 days
Trial: 21960068
Drug: Dorzolamide/timolol-fixed combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide/timolol-fixed combination (DTFC)
Trial: 15969661
Drug: Salmeterol 50μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50μg twice daily in addition to fluticasone 200μg
Trial: 12121563
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of allopurinol (AL) at 20 mg/kg/day plus low-dose MA at 30 mg/kg/day for 20 days
Trial: 7732340
Drug: Mesalazine suppositories
RxNorm normalized name: mesalamine Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine suppositories
Trial: 21156071
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 30-70 mg/d
Trial: 23356790
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) (all doses)
Trial: 17577644
Drug: NP101 (iontophoretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NP101 (iontophoretic sumatriptan patch)
Trial: 17577644
Drug: NP101 (iontophoretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NP101 (iontophoretic sumatriptan patch) delivering 6 and 12 mA per h
Trial: 17577644
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg subcutaneous injection of sumatriptan
Trial: 17577644
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral tablet of sumatriptan succinate
Trial: 15734604
Drug: Premelle 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premelle 2.5 mg (0.625 mg conjugated estrogen + 2.5 mg medroxyprogestorone)
Trial: 15734604
Drug: Kliogest (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kliogest (2 mg estradiol + 1 mg norethisterone)
Trial: 15734604
Drug: Livial (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Livial (2.5 mg tibolone)
Trial: 7582401
Drug: Niceritrol (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niceritrol (750 mg/day)
Trial: 7582401
Drug: Niceritrol (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niceritrol (750 mg/day) after fluvastatin (30 mg/day)
Trial: 7582401
Drug: Niceritrol (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niceritrol (750 mg/day) and Fluvastatin (30 mg/day)
Trial: 29702271
Drug: Hyoscine-N-Butylbromide (HBB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine-N-Butylbromide (HBB) 20 mg
Trial: 18791718
Drug: Tocosol Paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocosol Paclitaxel (175 mg/m2, 15 min intravenous infusion)
Trial: 18791718
Drug: Taxol (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxol (175 mg/m2, 3 h intravenous infusion)
Trial: 14726744
Drug: No Immunoglobulin
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Immunoglobulin (Ig) therapy
Trial: 8571936
Drug: rh IFN
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rh IFN alpha‐2b (150 x 10(4) IU: 3 MIU) administered three times a week
Trial: 8571936
Drug: Any administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Any administration schedule of rh IFN alpha‐2b
Trial: 8571936
Drug: Once a
RxNorm normalized name: Once A Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once a week administration schedule of rh IFN alpha‐2b
Trial: 2018005
Drug: 5-hydroxypropafenone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-hydroxypropafenone (300 mg, single oral dose)
Trial: 7036279
Drug: Adriamycin-cyclophosphamide (AC)
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin-cyclophosphamide (AC) chemotherapy
Trial: 7036279
Drug: AC chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC chemotherapy plus comprehensive regional radiotherapy
Trial: 31095313
Drug: Whey Protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey Protein Hydrolysate (WPH) 0.08 g/kg BW
Trial: 26075373
Drug: NPWT (negative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPWT (negative pressure wound therapy)
Trial: 9602957
Drug: Eprosartan 600
RxNorm normalized name: eprosartan 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan 600 mg, 800 mg, 1,200 mg once daily
Trial: 9602957
Drug: Eprosartan (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (various doses)
Trial: 29232162
Drug: Ly‐Lis (Insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ly‐Lis (Insulin Lispro)
Trial: 23211877
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg daily aglycone hypocotyl soy isoflavone supplementation
Trial: 15020520
Drug: Glibenclamide 10.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide 10.5 mg
Trial: 14578240
Drug: Multidisciplinary diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary diabetes outreach service (six monthly visits by a traveling team of specialist physicians, nurses, dieticians, and a pharmacist)
Trial: 11176729
Drug: High-dose lisinopril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose lisinopril
Trial: 8210967
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of lovastatin combined with 10 g of colestipol
Trial: 2946972
Drug: Morphine 5
RxNorm normalized name: ethylmorphine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 5 mg with 5 ml of 1% xylocaine
Trial: 2946972
Drug: Morphine with
RxNorm normalized name: opium alkaloids with morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine with normal saline 5 ml followed by xylocaine
Trial: 15737773
Drug: Concomitant vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant vaccination with Recombivax HB, Td, and MMR vaccines
Trial: 19293008
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (400 mg/kg/d for 5 days)
Trial: 8550251
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg per os)
Trial: 2213104
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy alone (control)
Trial: 2213104
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (both arms)
Trial: 2213104
Drug: Orchiectomy (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orchiectomy (initial endocrine therapy)
Trial: 2213104
Drug: Diethylstilbestrol (DES)
RxNorm normalized name: Diethylstilbestrol
DrugBank: Diethylstilbestrol (DB00255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylstilbestrol (DES) (initial endocrine therapy)
Trial: 8589000
Drug: G‐CSF
RxNorm normalized name: Granulocyte colony-stimulating factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF
Trial: 22422824
Drug: G‐CSF with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF with escalated-dose cytarabine
Trial: 18503773
Drug: Peginterferon alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa‐2a 180 mug/wk plus ribavirin 1000/1200 mg/day for 24 weeks
Trial: 15924511
Drug: Graded exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded exercise therapy (n = 87)
Trial: 10947756
Drug: Intrathecal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal bupivacaine 7.5 mg combined with preservative‐free ketamine 25 mg
Trial: 10947756
Drug: Intrathecal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal bupivacaine 10 mg alone
Trial: 1502426
Drug: Nimodipine therapy
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine therapy in addition to standard therapy
Trial: 6488686
Drug: Diazepam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.3 mg/kg) before ketamine
Trial: 30807424
Drug: Lidocaine gel
RxNorm normalized name: LIDOCAINE 4 g in 100 g EXTRACORPOREAL PATCH [Arthcal 4% Lidocaine Gel Patches]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine gel (2% transurethral)
Trial: 30059794
Drug: medications (d-cycloserine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: medications (d-cycloserine, alprazolam)
Trial: 24844787
Drug: PC-SOD (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-SOD (80 mg, intravenous)
Trial: 19497461
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nurse assessment and MMX result
Trial: 7555933
Drug: Injection sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection sclerotherapy and laser photocoagulation
Trial: 1362432
Drug: Injection sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection sclerotherapy
Trial: 1780416
Drug: Overall treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatments (Nicotine, Silver Acetate, Ordinary chewing gum)
Trial: 28791802
Drug: Immediate-release prednisolone
RxNorm normalized name: prednisolone Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release prednisolone
Trial: 24080993
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate (AA) 1000 mg plus prednisone 5 mg b.i.d.
Trial: 24080993
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus prednisone 5 mg b.i.d.
Trial: 23419915
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of estimation accuracy between individual therapy sessions and circuit class therapy
Trial: 20713475
Drug: Once-daily budesonide/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily budesonide/formoterol (80/4.5 microg x2 inhalations; 160/9 microg daily)
Trial: 20713475
Drug: Twice-daily budesonide/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-daily budesonide/formoterol (40/4.5 microg x2 inhalations; 160/18 microg daily)
Trial: 7006789
Drug: CCNU (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCNU (100 mg/m2 p.o. q. 6 weeks)
Trial: 7006789
Drug: BCNU (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCNU (200 mg/m2 p. 6 weeks)
Trial: 30767788
Drug: Citrulline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrulline (2 g/day)
Trial: 23010339
Drug: Broad-spectrum antibiotic
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-spectrum antibiotic treatment for 7 days
Trial: 18375021
Drug: PCV7 (7-valent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCV7 (7-valent pneumococcal conjugate vaccine) administered > or =7 days before DTaP
Trial: 18375021
Drug: PCV7 (7-valent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCV7 (7-valent pneumococcal conjugate vaccine) administered with DTaP
Trial: 8872694
Drug: Intravenous glycopyrrolate
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glycopyrrolate
Trial: 22763312
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline solution)
Trial: 10321444
Drug: Felodipine-metoprolol 5/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine-metoprolol 5/50 mg o.d. (Logimax)
Trial: 2516430
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy (control)
Trial: 30740658
Drug: Interventions based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interventions based on gait analysis (including physical therapy, orthotics, spasticity management, and orthopedic surgery)
Trial: 28320541
Drug: Ketorolac (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac (20 mg)
Trial: 20478449
Drug: Prednisolone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (30 mg)
Trial: 25869627
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of cycloserine (250, 500, or 1000 mg)
Trial: 25869627
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of cycloserine 250 mg BID for 5 days
Trial: 19825504
Drug: Duloxetine (60-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (60-120 mg/day)
Trial: 8273133
Drug: EPO (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPO (all doses)
Trial: 2528983
Drug: h alpha
RxNorm normalized name: FSH alpha
DrugBank: Follitropin (DB00066)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: h alpha CGRP infusion (1.5 micrograms min‐1 i.v.)
Trial: 26256216
Drug: Nonpharmacologic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpharmacologic therapies (NPTs) provided to nursing home residents, including an online course for physicians and a 1-day seminar for nurses.
Trial: 16394797
Drug: Interferon and
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon and ribavirin treatment in IVDUs
Trial: 6329980
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg X 2/die) and sucralfate (1 gr X 2/die)
Trial: 323118
Drug: Cimetidine 1
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1 g/day
Trial: 6329980
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg/b.i.d.
Trial: 24785761
Drug: Striatal dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Striatal dopamine D2/3 receptor availability in obese subjects
Trial: 22468623
Drug: Heat-killed Lactobacillus
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat-killed Lactobacillus plantarum L-137 (10 mg tablet)
Trial: 22468623
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (matching tablet)
Trial: 17418384
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray, 110 microg once daily
Trial: 18517083
Drug: Prednisone, 10
RxNorm normalized name: PredniSONE, 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone, 10 mg once daily
Trial: 10591389
Drug: High-intensity oral
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity oral anticoagulants (INR, 2.8-4.8)
Trial: 10591389
Drug: Moderate oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate oral anticoagulants (INR, 2-3)
Trial: 10591389
Drug: Moderate- to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate- to high-intensity oral anticoagulants (INR, >=2)
Trial: 10591389
Drug: Moderate- to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate- to high-intensity oral anticoagulants and aspirin
Trial: 10591389
Drug: Low-intensity oral
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity oral anticoagulants (INR, <2.0) and aspirin
Trial: 12784106
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum 2 mg
Trial: 21793279
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg low molecular weight iron-dextran intravenously in two doses (Group A)
Trial: 21793279
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg daily for 30 days of iron protein-succinylate (Group B)
Trial: 15220185
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity with IL-6 infusion (LO + IL-6)
Trial: 15220185
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity without IL-6 infusion (LO)
Trial: 7171413
Drug: Caudal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal analgesia with 0.5% bupivacaine plain and morphine sulphate
Trial: 29512121
Drug: Intra-articular ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular ketorolac (5 mg)
Trial: 24261316
Drug: Donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 5 mg once daily added to gabapentin (maximum 2400 mg daily)
Trial: 21309476
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg plain bupivacaine plus 25 mg meperidine (BM25)
Trial: 17599306
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole (250 mg 4 times per day) for 10 days
Trial: 17599306
Drug: Oral vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral vancomycin (125 mg 4 times per day) for 10 days
Trial: 7730907
Drug: Acetaminophen (10-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (10-15 mg/kg/dose)
Trial: 2913806
Drug: 0.25 ml
RxNorm normalized name: mineral oil 0.25 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 ml of 0.01% intracameral carbachol
Trial: 21681118
Drug: Standard-dose gefitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose gefitinib (250 mg daily)
Trial: 21681118
Drug: Low-dose gefitinib
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose gefitinib (dose reduced due to toxicities)
Trial: 18549692
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100 mg daily for 9 days starting on day 2 of menses
Trial: 18549692
Drug: Gonadotrophin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gonadotrophin 75 IU intramuscularly daily for 5 days starting on day 3 of menses
Trial: 16571154
Drug: High-phenol extra-virgin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-phenol extra-virgin olive oil (high-EVOO; 592 mg total phenols/kg)
Trial: 10858346
Drug: Imiquimod (IQ)
RxNorm normalized name: Imiquimod
DrugBank: Imiquimod (DB00724)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imiquimod (IQ) treatment
Trial: 9200356
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg rhSOD intratracheally